Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-07

FDA Approved: BICILLIN C-R 900/300 — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Bicillin C-R 900/300 (penicillin G benzathine and penicillin G procaine) from Pfizer. The action updates the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BICILLIN C-R 900/300 (Penicillin G benzathine and Penicillin G procaine)

Snippet

SUPPL AP for BICILLIN C-R 900/300 (PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE)